Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 5 hours 17 minutes
FTSE 100
8,117.46
+38.60
(+0.48%)
FTSE 250
19,833.83
+231.85
(+1.18%)
AIM
755.57
+2.45
(+0.33%)
GBP/EUR
1.1660
+0.0004
(+0.03%)
GBP/USD
1.2517
+0.0006
(+0.05%)
Bitcoin GBP
51,498.68
+585.32
(+1.15%)
PROPERTY
9 luxury homes to consider if money is no object
Ever thought about what a multimillion pound budget would buy you?
Sorrento Therapeutics, Inc. (SRNE)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0200
0.0000
(0.00%)
At close: 02:43PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,321
62,839
52,904
39,986
Cost of revenue
22,867
33,452
13,031
9,940
Gross profit
37,454
29,387
39,873
30,046
Operating expenses
Research development
239,317
221,226
206,922
111,340
Selling general and administrative
197,553
182,337
196,856
116,179
Total operating expenses
441,101
407,888
407,918
231,572
Operating income or loss
-403,647
-378,501
-368,045
-201,526
Interest expense
9,297
8,574
10,224
20,157
Total other income/expenses net
-116,372
-174,672
-84,259
-88,897
Income before tax
-529,316
-561,747
-462,528
-310,580
Income tax expense
-33,657
-2,416
-33,516
-2,014
Income from continuing operations
-495,505
-577,757
-429,138
-314,410
Net income
-493,568
-572,843
-428,325
-298,461
Net income available to common shareholders
-493,568
-572,843
-428,325
-298,461
Basic EPS
-1.10
-1.37
-1.45
-1.30
Diluted EPS
-1.10
-1.37
-1.45
-1.30
Basic average shares
507,859
419,315
294,774
229,823
Diluted average shares
507,859
419,315
294,774
229,823
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.